✦ LIBER ✦

A novel role of serum cytochrome c as a tumor marker in patients with operable cancer

✍ Scribed by Akemi Osaka; Hiroo Hasegawa; Yasuaki Yamada; Katsunori Yanagihara; Tomayoshi Hayashi; Mariko Mine; Muneo Aoyama; Takashi Sawada; Shimeru Kamihira

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 471 KB
Volume: 135
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-008-0479-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical evaluation of serum tumor-assoc

Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients

✍ Fiorella Guadagni; Mario Roselli; Teresa Amato; Maurizio Cosimelli; Ernesto Mann 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

A novel tumor marker, tumor-associated glycoprotein-72 (TAG-72), has been identified using monoclonal antibody (MAb) B72.3. Using immunohistochemical techniques, TAG-72 has been found in carcinomas of various origin including colon, stomach, breast, lung, prostate, and ovary, as well as in body flui

IgA With altered carbohydrate structure

IgA With altered carbohydrate structure as a tumor-associated marker in serum of cancer patients

✍ Jerry G. Henslee; Harry G. Rittenhouse; Matthew S. Matias; G. Michael Hass; Jay 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 728 KB

Serum lgAl contains 0-linked carbohydrate structures, whereas other immunoglobulins contain only N-linked structures. An assay was developed which detects lgAl by measuring the DGalP(1-3) DGalNAc structures 0-linked to the lgAl hinge region. Fifty percent of the serum specimens from cancer patients

Evaluation of serum laminin as a tumor m

Evaluation of serum laminin as a tumor marker in breast cancer

✍ G. Sidhom; M. Imam 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 359 KB

Clinical use of serum TRA-1-60 as tumor

Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer

✍ Henrik Lajer; Gedske Daugaard; Anna-Maria Andersson; Niels Erik Skakkebæk 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

## Abstract TRA‐1‐60 antigen has been related to the presence of embryonal germ cell carcinoma (EC) and carcinoma __in situ__. Our study further investigated the clinical efficacy of TRA‐1‐60 as a serum tumor marker for germ cell cancer in the testis. Three groups of patients with germ cell tumors

Serum cytochrome c indicates in vivo apo

Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy

✍ Katarzyna Barczyk; Michael Kreuter; Juliusz Pryjma; Evan P. Booy; Subbareddy Mad 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 248 KB

## Abstract Despite significant progress in cancer therapy, the outcome of the treatment is often unfavorable. Better treatment monitoring would not only allow an individual more effective, patient‐adjusted therapy, but also it would eliminate some of the side effects. Using a cytochrome c ELISA th

Serum ca 50 as a tumor marker in pancrea

Serum ca 50 as a tumor marker in pancreatic cancer: A comparison with CA 19-9

✍ Caj Haglund; Pentti Kuusela; Hannu Jalanko; Peter J. Roberts 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 459 KB

CA 50 is a new tumor marker based on a monoclonal anti-carcinoid tumor, 2 cystadenocarcinomas, 2 anaplastic carcibody (MAb) against a human colorectal carcinoma cell line.The nomas, 15 poorly differentiated and 39 well-to moderately-CA 50 antigen is similar, but not identical, to the tumor different